Category: Health

Categories
Health

Pfizer Begins Testing Its Vaccine in Younger Kids

Pfizer Begins Testing Its Vaccine in Young Children

Pfizer has started testing its Covid-19 vaccine in children under the age of 12. This is an important step in reducing the pandemic. The first participants in the study, a pair of 9-year-old twin girls, were vaccinated on Wednesday at Duke University in North Carolina.

Results of the study are expected in the second half of the year, and the company hopes to vaccinate younger children early next year, said Sharon Castillo, a spokeswoman for the drug company.

Moderna is also starting testing its vaccine in children aged six months to 12 years. Both companies have tested their vaccines in children 12 years and older and expect these results in the next few weeks.

AstraZeneca began testing its vaccine in children six months and older last month. Johnson & Johnson has announced plans to extend the vaccine trials to young children after assessing performance in older children.

Immunizing children will help schools reopen and end the pandemic, said Dr. Emily Erbelding, an infectious disease doctor at the National Institutes of Health who oversees the testing of Covid-19 vaccines in specific populations.

An estimated 80 percent of the population may need to be vaccinated for the United States to achieve herd immunity, the threshold above which the coronavirus can no longer infect people. Some adults may refuse to be vaccinated, while others may not produce a robust immune response.

Children under the age of 18 make up about 23 percent of the US population. Even if the vast majority of adults choose vaccines, “herd immunity may be difficult to achieve without vaccinating children,” said Dr. Erbelding.

Pfizer originally announced that it would wait for data from older children before starting trials of its vaccine in children under the age of 12. “We were encouraged, however, by the data from the group of 12-15 year olds,” said Ms. Castillo, who did not elaborate on results so far.

Scientists will test three doses of the Pfizer vaccine – 10, 20, and 30 micrograms – in 144 children. Each dose is assessed first in children aged 5 to 11 years, then in children aged 2 to 4 years, and finally in the youngest group aged six months to 2 years.

After determining the most effective dose, the company will test the vaccine on 4,500 children. Approximately two-thirds of the participants are randomly selected to receive two doses 21 days apart. The remainder received two placebo injections of saline solution. The researchers will study the children’s immune response in blood drawn seven days after the second dose.

Updated

March 25, 2021, 2:39 p.m. ET

“It sounds like a good plan, and it’s exciting to see another Covid-19 vaccine drive studies in children,” said Dr. Kristin Oliver, pediatrician and vaccine expert at Mount Sinai Hospital in New York.

Dr. Oliver said that about half of the parents she sees in the office eagerly await vaccines and even volunteer their children for clinical trials, while the rest are skeptical because comparatively few children get seriously ill with coronavirus infection .

Both parent groups will benefit from knowing exactly how safe and effective the vaccines are in children, she said.

Children make up 13 percent of all reported cases in the United States. More than 3.3 million children tested positive for the virus, at least 13,000 were hospitalized and at least 260 died, noted Dr. Yvonne Maldonado, who represents the American Academy of Pediatrics on the Federal Advisory Board on Immunization Practices.

The figures do not fully capture the damage to the health of children. “We don’t know how a Covid infection will affect the long term,” said Dr. Maldonado.

Other vaccines have helped fight many terrible teething problems that can cause long-term complications. She added, “For some of us who have seen this, we don’t want to go back to that time.”

Children are often more responsive to vaccines than adults, and infants and young children in particular can have a high fever. All side effects are likely to appear soon after the shot, within the first week, and certainly within the first few weeks, experts have said.

Some vaccines are only tested on animals before being studied in children and must be carefully monitored for side effects.

“But that’s a little different because we’ve already had tens of millions of people with these vaccines,” said Dr. Maldonado. “So there is more confidence to give this vaccine to children.”

Some experts suggested that the Food and Drug Administration may need up to six months of safety data from studies in children before the Covid-19 vaccines are approved. However, a spokeswoman said the agency did not expect safety data to support approval of the vaccines for six months.

The Pfizer BioNTech vaccine is approved for children ages 16-18, and approval for that age group was based on just two months of safety data, she said.

Parents will want to know how the companies and the FDA plan to monitor and disclose the side effects of the vaccines and how long they will pursue study participants after the vaccines are approved, said Dr. Oliver.

“I think everyone has learned that,” she said. “The more transparent you can be, the better.”

Categories
Health

Pfizer begins trial on infants and younger youngsters

U.S. ‘flying blindly’ when it comes to new Covid variant, says doctor

A healthcare worker prepares a vaccination for Pfizer coronavirus disease (COVID-19) in Los Angeles, California on January 7, 2021.

Lucy Nicholson | Reuters

Pfizer announced that it has started a clinical trial testing the Covid-19 vaccine in healthy children aged 6 months to 11 years. This is a critical step in gaining regulatory approval to vaccinate young children and fight the pandemic.

The first participants in the study have already made their recordings, which were developed in collaboration with the German drug manufacturer BioNTech, New York-based Pfizer announced on Thursday. In the first phase, 144 children are to be enrolled.

In the first phase of the study, the company will determine the preferred dosage level for three age groups – between 6 months and 2 years, 2 and 5 years, and between 5 and 11 years. The children will first receive a dose of 10 micrograms of the vaccine before gradually moving on to higher doses, Pfizer said. Participants also have the option of ingesting 3 micrograms doses. The adult Covid vaccine requires two shots that contain 30 micrograms per dose.

Researchers will then evaluate the safety and effectiveness of the selected dose levels in the next phase of the study, with participants being randomly selected to receive the vaccine or a placebo, the company said. After a six-month follow-up visit, children who received a placebo will have the option to receive the vaccine.

“Pfizer has extensive experience developing clinical trials of vaccines in children and infants and is committed to improving the health and well-being of children through well-designed clinical trials,” the company said in a statement.

Pfizer’s vaccine has already been approved for use in the United States by Americans 16 and older. Clinical studies testing the vaccine in children whose immune systems may react differently than adults are still to be completed.

Vaccinating children is critical to ending the pandemic, say public health officials and infectious disease experts. The US is unlikely to achieve herd immunity – or if enough people in a given community have antibodies to a given disease – before children can be vaccinated. According to the government, children make up around 20% of the US population.

In late January, Pfizer announced that it had fully registered the Covid-19 vaccine study for children ages 12-15. The company announced Thursday that the data in this cohort was “encouraged” and hopes to provide more details about the study. soon.”

Moderna, which also has a US-approved vaccine, announced on March 16 that it has started testing its shot in children under the age of 12. Moderna started a study in December testing children aged 12 to 17 years.

Johnson & Johnson plans to test its single-shot vaccine in infants and even newborns after it was first tested in older children, according to the New York Times.

The Chief Medical Officer of the White House, Dr. Anthony Fauci, speaking to a House committee earlier this month, said the U.S. could vaccinate older children against Covid-19 starting this fall, while elementary school-age children may get their shots early next year.

Pfizer’s announcement comes two days after the start of an early-stage clinical trial of an experimental oral antiviral drug that could be used at the first sign of Covid infection.

Health experts say the world will still need a slew of drugs and vaccines to end the pandemic that has infected more than 30 million Americans and killed at least 545,282 people in just over a year, according to Johns Hopkins University.

Categories
Health

AstraZeneca’s Newest Stumble Once more Clouds European Vaccinations

AstraZeneca’s Latest Stumble Again Clouds European Vaccinations

LONDON – This week’s announcement that the AstraZeneca shot, the workhorse of global vaccine adoption, was nearly 80 percent effective in a gold-standard American study was facilitated by the many countries that rely on it.

“If you get the call, get the bump,” urged UK Health Secretary Matt Hancock, part of a campaign by European lawmakers to calm people’s nerves with the shot after a recent security crisis.

But by Tuesday that campaign was off course, at least for the moment. For AstraZeneca, it appeared to be yet another episode of public relations whiplash, part of a string of recent mistakes and communications errors by the company that scientists said undermined efforts to sell people with one of the most effective and essential coronavirus vaccines.

In a highly unusual move, American health officials said Tuesday that the company’s report on the results of its US studies was not entirely accurate, suggesting that AstraZeneca used only the most favorable data to produce what appeared to be spectacular efficacy results.

These comments sparked new tensions between AstraZeneca and American officials, despite the company battling for coveted Food and Drug Administration approval. More urgently, however, she wrench the efforts of elected leaders around the world to restore confidence in a shot that, due to its low price and simple storage requirements, has rebuilt the backbone of many countries’ campaigns to end the pandemic have provided.

“It weakens confidence,” said Simon Clarke, associate professor of cell microbiology at the University of Reading. “If you pump things up and people don’t question it inappropriately, it undermines trust.”

Confidence in the vaccine had already fallen across Europe after it was recently reported that a very small number of recipients had developed unusual blood clots.

In France, Germany, Italy and Spain today, more people believe the vaccine is unsafe than it is safe. Polls have shown that this is a blow to a shot that remains the continent’s best hope of saving people’s lives amid a growing number of new infections. Millions of cans are used unused in refrigerators across the continent. Doctors report that some people stop injections because of concerns about side effects.

Despite the much worrying news about the vaccine, European and global regulators have found it safe and effective. In the UK alone, more than 11 million doses have been administered, almost all of which have no serious side effects. This led to hospital admissions and helped the country get out of a terrible wave of infections over the winter.

Even so, AstraZeneca’s US trial was eagerly awaited. It had been expected to be the largest of its kind for the shot and to give the cleanest, most complete picture of the vaccine’s effectiveness. American officials saw it as an irrefutable test of the vaccine’s performance.

And health officials around the world saw this as a crucial guide for their own rollouts: it would provide vital data on the elderly who weren’t as well represented in previous studies and a more accurate reading of the vaccine’s overall effectiveness. which from previous attempts had appeared lower than that of other leading shots.

As soon as AstraZeneca announced its results on Monday, stating that the vaccine had 79 percent effectiveness in preventing symptomatic Covid-19, lawmakers cited it as part of their fledgling efforts to build public confidence in the vaccine.

By Tuesday, scientists said, it appeared AstraZeneca had punched a hole in those efforts. Rather than clarifying questions about the shot, it had recalled communication issues that have haunted the company since last year, delaying the regulatory process in some regions, and causing hesitation among some recipients.

Updated

March 25, 2021, 8:30 a.m. ET

So far, according to the block, only 55 percent of the AstraZeneca doses shipped to the European Union have been placed in people’s arms, which is well below the rate of use for other vaccines. Around seven million cans are still in the fridge.

While some countries have given more than 70 percent of their doses, others are struggling to get them off the shelves: Germany and France have given about half of their AstraZeneca shipments, and Luxembourg has only given a third.

Scientists said such public dusting was extremely unusual between the American medical experts overseeing a study and the company sponsoring it.

“It’s usually done privately,” said Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine, of any disagreement. “That is unprecedented in my opinion.”

In its first public comments, AstraZeneca said the results released on Monday mirrored US testing data through February 17. The preliminary assessment of more complete trial data found that “results are in line with interim analysis” said it would share more timely efficacy results within 48 hours.

Scientists said the problem might still turn out to be a technical matter that didn’t change their assessment of the vaccine. American officials did not suggest that security issues had been withheld, which was of great concern given concerns in Europe.

Even so, it quickly took the wind out of the sails of the European legislature’s public campaign to restore confidence in the shot developed with Oxford University. In the past few days, a number of political leaders, including British Prime Minister Boris Johnson and French Prime Minister Jean Castex, have received the vaccine itself to show people it is safe.

“I literally felt nothing,” Mr Johnson told reporters. “I don’t recommend it too much.”

Tuesday’s stumble was the latest in a series of mistakes that have created a troubled relationship between AstraZeneca and American and European regulators – and which scientists say has created unnecessary public confusion over a vaccine that appears to be highly effective.

In early September, the company silently halted its worldwide trials after a participant in the UK fell ill. But American regulators didn’t find out until the story became public. The company’s slowness in providing the FDA with evidence that its vaccine has not been linked to disease kept it on the ground for nearly seven weeks. AstraZeneca has announced that data will be exchanged in a timely manner.

By the end of November, the company was back at a high level: it published results of early clinical studies, including in the UK, that showed the vaccine was either 62 percent or 90 percent effective, depending on the type of dosage.

But even these results were quickly clouded by uncertainty. AstraZeneca later admitted that there was initially confusion about the dose of vaccine some study participants received, making the results difficult to interpret.

The UK, which has long advocated the home-grown vaccine, approved the shot in late December, citing earlier results from clinical trials. The European Union Medicines Agency did the same, but a month later.

EU officials said the delay was partly due to a back and forth between regulators and AstraZeneca over the quality of the data.

And even after the vaccine was approved, some European countries initially restricted it to younger people due to insufficient data on its effectiveness in the elderly. This problem was to be solved through the American process, in which the elderly were better represented.

Neither the European nor the UK regulators gave any indication on Tuesday that the problems with AstraZeneca’s American data would affect its launch there. These agencies relied on a separate dataset from non-American studies to approve the vaccine.

“We are in contact with the company regarding this additional information,” the European Medicines Agency said in a statement on Tuesday, “and the EMA will evaluate the relevant data as soon as the company provides it to us.”

Matina Stevis-Gridneff contributed to reporting from Brussels.

Categories
Health

EU, UK in talks over provides after new export guidelines

EU, UK in talks over supplies after new export rules

Nursing staff is waiting for the vaccine against COVID 19 from AstraZeneca at the sports center of the University of CUS Turin on March 14, 2021 in Turin, Italy.

Stefano Guidi | Getty Images News | Getty Images

LONDON – Britain and the European Union try to settle a dispute over Covid-19 vaccine supplies shortly after EU officials announced stricter rules on the export of block-made shots.

The UK and the EU have been at odds for the past few weeks, with the latter complaining that London has not had the same level of reciprocity when it comes to distributing vaccines. The EU has said that since the end of January, more than 10 million cans produced in the EU have gone to the UK, but the UK has not exported any in return.

“We are all facing the same pandemic, and the third wave makes EU-UK cooperation even more important. We discussed what more we can do to promote a mutually beneficial relationship between the UK and the EU on Covid -19 to ensure. ” The UK government and the European Commission announced this in a joint statement on Wednesday.

“Given our interdependencies, we are working on specific steps that we can take in the short, medium and long term to create a win-win situation and expand the vaccine supply for all of our citizens,” said the UK and EU, adding in addition, these discussions would continue.

At the center of the recent dispute is the fact that the EU has received significantly fewer vaccines from AstraZeneca than expected, which puts further adoption at risk.

The Anglo-Swedish pharmaceutical company was expected to distribute around 90 million doses in the first quarter, but that number has since been reduced to 30 million doses.

Our export authorization mechanism is not regulated in any particular country.

Valdis Dombrovskis

EU head of trade

AstraZeneca, which developed its Covid vaccine in partnership with Oxford University, said yield problems at EU facilities have hampered production. So far, only 17 million doses have been distributed to EU countries, according to the European Center for Disease Prevention and Control.

EU leaders will hold a virtual summit on Thursday to discuss ways to improve supplies of Covid vaccines and improve the introduction of doses.

Export rules

EU countries suffered another setback after AstraZeneca cut its delivery target for the second quarter from 180 million to 70 million cans.

“I remind you that AstraZeneca has only fulfilled a small part of its agreed contractual obligations,” said Valdis Dombrovskis, EU chief of trade, at a press conference on Wednesday.

As a result, the European Commission decided to tighten the rules for the export of block-made vaccines. The EU executive said on Wednesday that in addition to checking that companies are performing their contracts, it also takes into account whether the country that receives vaccines made in the EU has a higher vaccination rate and better epidemiological situation overall, and whether the recipient nation has restrictions on shipping vaccines or raw materials to other locations.

For this reason, the UK could expect a lower number of imported Covid recordings in the future. It has a higher vaccination rate than the EU and, according to the EU Commission, does not share its vaccines with other nations.

“Our export licensing mechanism is not regulated in any particular country, but it is clear that we in the EU must also ensure that our own people are vaccinated,” said Dombrovskis.

British Prime Minister Boris Johnson said Wednesday that blocking vaccines made “no sense”.

Over the weekend, Italian authorities discovered 29 million doses of Oxford-AstraZeneca vaccines at a processing facility near Rome. AstraZeneca said in a statement that these shots were waiting for quality control and that 13 million should be shipped to low and middle income countries and the remaining 16 million doses to EU countries, with 10 million expected in the last week of March be sent.

“It is wrong to call this inventory. The process of making vaccines is very complex and time-consuming. In particular, vaccine doses have to wait for quality control clearance after the vials are filled,” AstraZeneca said in a statement.

Categories
Health

New Zealand Approves Paid Depart After Miscarriage

New Zealand Approves Paid Leave After Miscarriage

AUCKLAND, New Zealand – New Zealand’s parliament unanimously passed a law on Wednesday granting three days of paid leave to couples who suffer a miscarriage or stillbirth, making the country the vanguard of those performing such services.

Ginny Andersen, the Labor MP who drafted the bill, said she could not find legislation like it anywhere in the world. “We may be the first country,” she said, “but all of the countries where New Zealand is usually compared to legislation for the 20 week mark.”

Employers in New Zealand, as in some other countries, were already required to grant paid leave in the event of a stillbirth if a fetus is lost after a pregnancy of 20 weeks or more. The new legislation will expand this possibility to anyone who loses a pregnancy at any time, removing any confusion. The measure is expected to take effect in the coming weeks.

“I felt that it would give women the confidence to apply for this vacation when they need to, rather than just being stoic and getting on with life when they knew they needed time, physically or mentally, to read about it to get over grief, ”said Ms. Andersen.

The new law does not apply to those who terminate pregnancies, Ms. Andersen added. New Zealand decriminalized abortion last year, ending the country’s status as one of the few wealthy nations to limit reasons for terminating a pregnancy in the first half.

In Australia, people who have a miscarriage are entitled to unpaid leave if they lose a fetus after 12 weeks, while in the UK prospective parents who have a stillbirth after 24 weeks are entitled to paid leave. The United States does not require employers to take vacation leave for anyone who experiences a miscarriage.

According to the Mayo Clinic, up to 20 percent of all known pregnancies in the United States result in a miscarriage. In New Zealand, which has a population of five million, the Department of Health estimates that one to two pregnancies in ten will result in a miscarriage.

Sands New Zealand charity, which supports parents who have lost pregnancies, says 5,900 to 11,800 miscarriages or stillbirths occur each year. According to the New Zealand College of Midwives, more than 95 percent of miscarriages occur in the first 12 to 14 weeks of pregnancy.

A miscarriage or stillbirth remains a difficult and painful topic that health lawyers say is difficult to talk about in public or seek support.

“If you call the hospital and say,” I think I miscarried my baby, “so many women will say,” I felt like the first person in the world to miscarry, “said Vicki Culling. an educator on baby loss who advocated better support for the bereaved in New Zealand.

“The very foundations of your world are crumbling just because you expect to have this beautiful baby, and when that baby dies, whether in the womb or shortly after birth, everything is broken.”

Ms. Culling welcomed New Zealand legislation as a first step, but said more needed to be done.

“You get three days of paid vacation, maybe you bury your baby or you have a job, and then you go back to work and carry on – and then what? That’s my concern, ”she said.

“I celebrate, but I want us to maintain that compassion and delve deeper into the needs of these parents.”

Categories
Health

Fauci says AstraZeneca will seemingly concern modified assertion

Fauci says AstraZeneca will likely issue modified statement

Anthony Fauci, director of the National Institute for Allergies and Infectious Diseases at the NIH, speaks about the daily press conference at the White House in Washington on January 21, 2021.

Jonathan Ernst | Reuters

AstraZeneca is likely to release a modified statement on its Covid-19 vaccine after questioning the accuracy of the company’s clinical trial results earlier this week, said Dr. Anthony Fauci, Chief Medical Advisor of the White House, on Wednesday.

The company announced on Monday the long-awaited results of its Phase 3 clinical trial of the Covid-19 vaccine it was developing at Oxford University. It is 79% effective in preventing symptomatic diseases and 100% effective against serious illness and hospitalization.

The next day, the National Institute of Allergy and Infectious Diseases released an unusual statement informing it from the Data and Safety Monitoring Board (DSMB) overseeing the study that the UK-based company may have included information in its US results which provided an “incomplete view of the efficacy data”.

Fauci, director of NIAID, said the DSMB has raised concerns with the U.S. agency because it believes the results in AstraZeneca’s press release are more favorable than more recent data from the vaccine study showed, according to STAT News.

The company is now working with the DSMB and “is likely to make a modified statement,” Fauci told reporters Wednesday during a White House press conference on the pandemic.

Public health and vaccines experts told CNBC that AstraZeneca’s data problem is just the latest example of a series of mistakes by the company that could affect people’s willingness to take the vaccine, which may be approved in the US as early as next month becomes.

President Joe Biden’s senior advisor on the pandemic, Andy Slavitt, attempted to reassure Americans about the vaccines on Tuesday, telling CNN: “The public should be confident that nothing will be approved if the FDA gets this data not thoroughly analyzed. “

When the AstraZeneca vaccine is reviewed by the FDA, the agency will “judge what the data says or what it says and whether or not it is approved. Until then, this is all just stuff that will do it.” happen in the background, “said Slavitt.” We believe this transparency and scientific independence are critical to public trust.

AstraZeneca’s vaccine is already approved for use in other countries. The company said in a statement Tuesday that it intends to release results of its primary analysis of the Covid-19 vaccine “within 48 hours”.

Categories
Health

Mississippi Will Take away ‘Deceptive’ Language About Covid-19 Vaccine

Mississippi Will Remove ‘Misleading’ Language About Covid-19 Vaccine

Bobby Wayne, a retired minister with prostate cancer and leukemia, had called health officials in his Mississippi county for a week to find out where to get the Covid-19 vaccine.

But when Mr. Wayne, 64, called the state helpline on Monday, he said an operator whose job it was to help residents schedule vaccination appointments had given him annoying and inaccurate information.

“That’s how she told me: They had no documentation that the vaccine was effective,” Wayne said. “And then she asked me if I still wanted to take it.”

When he said “yes” to her, the operator replied that there were no appointments available and that he should call again the next morning.

Recognition…Elizabeth Wayne

The confusion was the result of “miscommunication” about a misleading script that the hotline operators had received, according to the Ministry of Health.

The script referred to pregnant women, breastfeeding women and people with weakened immune systems.

It was asked, “Still want to be vaccinated with the understanding that no data are currently available on the safety or effectiveness of Covid-19 vaccines, including the Moderna Covid-19 vaccine, in pregnant women, breastfeeding women or the immunocompromised?”

Most experts agree that the risks to pregnant women from Covid-19 are far greater than any theoretical harm from the vaccines. Doctors have said they believe the vaccines are safe for people with autoimmune diseases.

Liz Sharlot, a spokeswoman for the Mississippi Department of Health, said the script could be confusing “if read out of context.”

Updated

March 24, 2021, 9:11 p.m. ET

“We are replacing this confusing and misleading language,” she said in a statement

However, Ms. Sharlot said operators were never told that there was no documented evidence that the Moderna vaccine, or any other vaccine approved by the Food and Drug Administration, worked.

“Just the opposite is the case,” she said. “Both Moderna and Pfizer have high rates of effectiveness.”

Ms. Sharlot added, “I think the Lord misunderstood this.”

Mr. Wayne said he understood perfectly.

“I’m not confused at all,” he said. “I’m maybe 64 years old and disabled, but my brain is still working and so are my ears.”

Mr. Wayne said it was worrying to think that people asking for information about the vaccination might be discouraged by the very people who are supposed to help them get a shot.

“I wouldn’t want anyone else to go through this,” he said.

According to a New York Times database, Mississippi has given 22 percent of its population at least one dose of a Covid-19 vaccine. Just over 12 percent of citizens are fully vaccinated.

Mr. Wayne’s daughter, Elizabeth Wayne, an assistant professor of biomedical engineering at Carnegie Mellon University, complained on Twitter about her father’s conversation with the state operator, calling it “violence.”

“It’s dangerous,” said Dr. Wayne. “There is therapy. There is a way to treat something and you make it harder for them to get access to that treatment, making it more likely that they will get sick. “

The Mississippi Free Press covered the story after Dr. Wayne wrote on Twitter about her father’s experience.

Dr. Thomas E. Dobbs III, the state health commissioner, responded to her post on Twitter and shared a link to a study in the New England Journal of Medicine that showed the Moderna vaccine, Covid-19, was 94.1 percent effective prevented and that “No safety concerns were identified. “

Dr. Wayne said she was pleased that the health department appeared to be taking her and her father’s concerns seriously.

“I think it was a really good example of the State Health Department trying to contact because they actually want to restore confidence,” she said.

Mr. Wayne said he got his shot Wednesday morning.

“I feel a lot better,” he said.

Categories
Health

CDC eviction ban will quickly expire. Specialists warn of a Covid surge

CDC eviction ban will soon expire. Experts warn of a Covid surge

Protesters gather for a rally to support bills and laws to block evictions in Massachusetts for up to a year.

Boston Globe | Boston Globe | Getty Images

The country’s attempts to bring the coronavirus pandemic under control could be undermined by the impending expiration of the national eviction ban, experts warn.

Centers for Disease Control and Prevention’s moratorium on most evictions across the country has been in place since September 2020, but is set to expire in a week.

According to a survey published this month by the Census Bureau, around one in five adult renters say they haven’t paid last month’s rent. Closer to 1 in 3 black tenants said the same thing.

According to a recent study, continuing the mass evictions could lead to an increase in cases and deaths in Covid.

More from Personal Finance:
Four months behind the rent he got help from his landlord
More than 2,000 organizations are calling on Biden to extend the eviction ban
What you should know about applying for a portion of the $ 45 billion rental allowance

That’s because many displaced people double up with family members or friends, or are forced to turn to overcrowded shelters.

During the pandemic, 43 states and Washington, DC temporarily banned evictions. Many of the moratoriums only lasted 10 weeks, while some states continue to ban the process.

The researchers found that continuing evictions in these states between March and September caused 433,700 cases of Covid-19 and 10,700 additional deaths in the U.S. before the CDC ban went into effect nationwide.

“If you look at an infectious disease like Covid-19, evictions can have implications not only for the health of displaced families, but the health of the wider community,” said Kathryn Leifheit, one of the study’s authors and a postdoctoral fellow at UCLA Fielding School of Public Health.

Evicting tenants is a last resort, said Bob Pinnegar, president of the National Apartment Association. However, the last year has marginalized the landlords, he said.

“Over 50% of rental housing providers in the country are mom and pop owners who rely on their few housing units as their only source of income,” he said. “The reserves are running out and in many cases are exhausted.”

The CDC has sent the Bureau of Administration and Budget a proposal to review the rules, which experts say indicates that the health authority is taking steps to maintain protection.

The Washington Post reported Wednesday that the ban can be extended through July.

CDC spokesman Jason McDonald said a decision to extend the moratorium had not been made. And the White House did not immediately respond to a request for comment.

Meanwhile, housing advocates are watching the clock and saying the ban must be in place at least until the historic cash pot allocated by Congress for rent arrears is distributed.

“An expired moratorium only increases disease transmission and defeats the purpose of the $ 45 billion grant,” said Emily Benfer, eviction expert and visiting law professor at Wake Forest University.

Categories
Health

Free With Your Covid Shot: Beer, Arcade Tokens and Krispy Kreme Doughnuts

Free With Your Covid Shot: Beer, Arcade Tokens and Krispy Kreme Doughnuts

The benefits of vaccination against Covid-19 – namely, protection against a dangerous virus – should be obvious at this stage of the pandemic.

If that’s not enough, consider swag.

Companies in the U.S. and beyond are offering free merchandise and other items to people receiving Covid shots. The perks include free rides, donuts, cash, arcade tokens, and even marijuana.

Behavioral motivation experts say offering incentives isn’t necessarily the most effective or inexpensive way to increase vaccine intake. But that hasn’t stopped the freebies from piling up.

In Cleveland, Market Garden Brewery is offering 10-cent beers to the first 2021 people to show a Covid-19 vaccine certificate. “Yes, you read that right,” says the brewery on its website. “Ten cents.”

At the greenhouse at Walled Lake, a Michigan medical marijuana dispensary, anyone aged 21 and over who is receiving a Covid vaccine can pick up a pre-rolled joint by the end of the month.

Chobani offers free yogurt at some vaccination sites. And Krispy Kreme said Monday that for the rest of the year, anyone with evidence of Covid-19 vaccination would be given one glazed donut a day.

As vaccinations accelerated in the United States, “We made a decision, ‘Hey, we can support the next act of joy.” When you come by, show us a vaccination card and pick up a donut anytime you want, any day, ”company executive director Michael Tattersfield told Fox News.

The Krispy Kreme initiative has nothing to do with the “vaccinated donuts” that were sold by a bakery in Germany last month and are garnished with plastic syringes that dispense a sweet lemon-ginger amuse-bouche. Nor does it entitle vaccinated Americans to endless donuts, as Mr. Tattersfield seemed to imply in his Fox News interview – only one a day, as the company notes on its website.

In a promotion called “Tokens for Poke’ns,” Up-Down, a chain of bars with vintage arcade games, is offering free tokens worth $ 5 to guests who present a completed vaccination card. Up-Down, with six locations in five states of the Midwest, expands the offering to guests who visit within three weeks of the final ingestion.

Up-Down’s communications manager David Hayden said he got the idea while sitting in an observation room after receiving his own vaccine.

“It’s something we’ve been expecting for so long,” he said, adding that the token giveaway was a way to give customers something different to look forward to after vaccination.

Cleveland Cinemas, an Ohio cinema chain, is offering free 44-ounce popcorn at two locations to anyone who presents a vaccination card by April 30th.

To encourage younger people to get vaccinated, Tel Aviv city set up a mobile vaccination clinic in a bar last month and offered free beer and non-alcoholic peach juice to those who received a shot, The Times of Israel reported.

Showing cards for so many promotions can cause wear and tear. To protect the cards from damage, Staples offers to laminate them for free after customers have received their final dose. The promotion runs until May 1st.

Some vaccination benefits flow from companies to their employees. Tyson Foods, Trader Joe’s, and others pay for the time it takes to get vaccinated, while Kroger pays them a $ 100 bonus.

Other incentives are aimed at people in vulnerable groups. For example, Uber has agreed to offer seniors, key workers and others in countries in North America, Europe and Asia 10 million free or discounted trips to help them access vaccination centers.

“Governments like these initiatives because they help them get more vaccines in more guns,” said Chris Brummitt, a spokesman for the company in Singapore.

That may be true, but the science of getting people to vaccinate is complex.

“Behavioral nudges,” based on scientific observations, could be a cheaper way to convince people to get the Covid-19 vaccine than direct incentives, said Hengchen Dai, professor of management at the University of California at Los Angeles .

In a recent study, Ms. Dai and her colleagues found that text messages can encourage people to receive influenza vaccinations. The most effective texts were framed as a memento to preserve recordings that were already reserved for the patient. They also resembled the type of communication patients expect from healthcare providers.

Jon Bogard, a PhD student at UCLA who contributed to the study, said policy makers should be cautious about incentives as they can sometimes backfire. One problem is that the campaigns are expensive, he said. Another reason is that people who receive gunshots might see a huge incentive as a sign that “vaccines are riskier than they actually are”.

A better alternative, Bogard said, might be to hand out “low personal value, high social value” items – such as stickers and badges – that convey a greater sense of “social motivation and accountability”.

There seems to be no shortage of such loot swirling around the world’s hospitals and vaccination clinics.

“Protected!” says a button that patients receive at a vaccination center in Hong Kong. It shows a cartoon syringe fist poking a masked doctor.

At a small league ballpark in Hartford, Connecticut, people who are shot can pick up a sticker that reads “I got my Covid-19 shot” featuring the home team’s mascot, a goat.

If you are not satisfied with the vaccine-style equipment at your local clinic, there are numerous options available to purchase online.

A badge – “I have my Fauci ouchi” – pays homage to America’s most famous doctor, Dr. Anthony S. Fauci.

“Thank you, science,” says another.

Categories
Health

Covid fraud prices Individuals $382 million

Covid fraud costs Americans $382 million

Visoot Uthairam | Moment | Getty Images

Covid pandemic-related fraud has cost Americans $ 382 million, according to the Federal Trade Commission.

By Tuesday, according to the federal government, more than 217,000 people had submitted a coronavirus-related fraud report to the agency since January 2020. The median loss was $ 330.

The losses for seniors were higher, however – $ 500 for people in their 70s and $ 900 for people in their 80s.

More from Personal Finance:
IRS makes more people eligible for $ 10,200 unemployment tax break
Deferred tax savings can help you get a $ 1,400 stimulus check
The deadline for subsidized health insurance has been extended to August 15

Criminals have used multiple avenues to steal money from unsuspecting Americans, including crimes related to financial relief such as stimulus checks and unemployment benefits, fake treatments for Covid-19, and fraudulent charities.

“While people fear for their health and finances, scammers have a big day,” Lucy Baker, a consumer advocate for US PIRG, told CNBC.

The Bureau of Consumer Financial Protection filed 542,300 pandemic-related complaints in 2020, up 54% from 2019.

Americans filed more than 3,000 complaints almost every month as of April 2020 that mentioned coronavirus keywords, according to the Bureau, a federal agency that oversees consumer financial misconduct.

“The pandemic was one of the most disruptive long-term events we will see in our lives,” said Dave Uejio, acting director of the CFPB. “Unsurprisingly, the shock waves it sent across the planet were felt deep in the consumer financial market.”

Complaints about credit and consumer reports made up more than 58% of all complaints, followed by complaints related to debt collection (15%), credit card (7%), check or savings (6%) and mortgage (5%). Not all of these complaints were necessarily related to Covid.

Identity theft was also a common problem related to unemployment benefits collected during the pandemic.

Around 60,000 people have reported identity theft to the FTC since last year. The U.S. Department of Labor launched a website Monday Monday for Americans whose personal information has been stolen and used to obtain fraudulent unemployment benefits.

Americans are also falling victim to scams related to the introduction of Covid vaccines.

According to Rublon, an online security company, early access vaccine scams were the most common cyber scams during the pandemic. Scammers send emails, texts, and phone calls claiming they have access to a vaccine from official government sources.

The FTC’s $ 382 million is likely to underestimate the scope of the fraud as it is based on incidents detailed by consumers. Many may not have been reported.

“We all need to be on our guard,” said Baker. “Before you click, take a break first.

“Do your research and ask yourself if this website, email, text, direct message, or phone call is legitimate,” she added. “Be careful when handing over your money or personal information.”